Tiragolumab(MTIG-7192A) is a monoclonal antibody that targets T-cell immunoglobulin and the ITIM structural domain (TIGIT).Tiragolumab is often used in combination with the PD-L1 inhibitor, Atezolizumab, for the treatment of solid malignant tumors such as non-small cell lung cancer.
Molecular Weight:
148.3 kDa
Purity:
98.80%
CAS Number:
[1918185-84-8]
Target:
Immunology/Inflammation related|||Others
T35392
* VAT and and shipping costs not included. Errors and price changes excepted